Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
doi: 10.1038/s41467-020-19152-7
2 weeks 1 vial Covers about 10 to 20 days at the example doses
Self-administering unregulated injectable substances carries serious risks, including infection, embolism, and systemic toxicity
intravenous TB-4 Phase 1 safety and pharmacokinetics, no dose-limiting or serious adverse events (Ann N Y Acad Sci 2010;1194:223229): NCT00743769 On February 27, 2026, HHS Secretary Kennedy announced that GHK-Cu is among approximately 14 peptides expected to return to Category 1
US$ 27.20
US$ 28.31
US$ 27.25
US$ 24.97
US$ 26.79
US$ 24.04
US$ 27.61
US$ 20.46
US$ 20.38
US$ 20.93
